Skip to content

Management of Astigmatism in Cataract surgery

Comparative analysis of management of Low Corndeal Astigmatism in Cataract surgery using different methods - NIL

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068526
Enrollment
400
Registered
2024-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Cataract surgery with PCIOL implantation with management of Astigmatism: All patients selected will undergo Cataract surgery with implantation of a Posterior Chamber Intraocular Lens a

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients both male and female 2.Aged above 50 years 3.With nuclear sclerosis of grade 1-4 (LOCS III), or posterior subcapsular cataract with pre existing regular corneal astigmatism between 0.75 D and 1.5 D on partial coherence interferometry (PCI) automated keratometry (IOLMaster 700, Carl Zeiss Meditec).

Exclusion criteria

Exclusion criteria: 1.Irregular astigmatism on tomography 2.Clinical or topographic keratoconus 3.Corneal scars 4.Corneal dystrophies 5.Peripheral corneal degenerations 6.Phacodonesis 7.Traumatic cataract 8.Intumescent cataract 9.Morgagnian cataract 10.Pseudoexfoliation 11.Previous ocular surgery 12.Other ocular pathology that could have an impact on capsular bag stability and on postoperative visual function 13.Any intraoperative or postoperative complications will be excluded from the study

Design outcomes

Primary

MeasureTime frame
Toric IOL has been proved to be the best and predicatble for management of astigmatism above 2D. For low corneal astigmatism FLAK and Manual LRI could be the good alternatives as compared to Cataract surgery onlyTimepoint: Patients will be evaluated postoperatively on day 1, 2 weeks and 12 weeks for the following tests 1.UDVA 2.BCVA 3.Refraction 4. IOL Master 700

Secondary

MeasureTime frame
Keratometry using IOL Master 70 (day 15 and 3months) iTrace for group D patients (day 15 and 3months) Timepoint: Keratometry using IOL Master 70 (day 15 and 3months) iTrace for group D patients (day 15 and 3months)

Countries

India

Contacts

Public ContactDR SADHWINI M H

Nethradhama Super Speciality Eye Hospital

sadhwiniharish@gmail.com7795568552

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026